FNY Investment Advisers’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-682
Closed -$2K 1347
2025
Q3
$2K Buy
+682
New +$1.93K ﹤0.01% 1068
2018
Q4
Sell
-7,500
Closed -$129K 953
2018
Q3
$129K Buy
7,500
+7,449
+14,606% +$111K 0.03% 244
2018
Q2
$0 Buy
+51
New +$861 ﹤0.01% 1046

Other funds holding PGEN

FNY Investment Advisers's PGEN Position: Q4 2025 in Review

FNY Investment Advisers sold out of Precigen (PGEN) in Q4 2025, closing a stake of 682 shares — an estimated $2K sold.

FNY Investment Advisers first reported a position in PGEN in Q2 2018 and held it in 3 quarters. The position peaked at $129K in Q3 2018. 179 funds tracked by Wall St. Rank hold PGEN as of Q4 2025.

  • FNY Investment Advisers reported no remaining Precigen position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 682 Precigen shares in Q4 2025, an estimated $2K.
  • FNY Investment Advisers first reported a position in Precigen in Q2 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Precigen position peaked at $129K in Q3 2018.
  • 179 funds tracked by Wall St. Rank held Precigen as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.